Skip to main content
Aarti Surfactants Limited logo

Aarti Surfactants Limited — Investor Relations & Filings

Ticker · AARTISURF ISIN · INE09EO01013 LEI · 335800PFHVXVPGNDID15 BSE.NS Manufacturing
Filings indexed 319 across all filing types
Latest filing 2026-01-31 Regulatory Filings
Country IN India
Listing BSE.NS AARTISURF

About Aarti Surfactants Limited

https://www.aarti-surfactants.com/

Aarti Surfactants Limited specializes in the production of ionic and non-ionic surfactants and specialty chemicals. The company serves diverse sectors, including home care, personal care, industrial applications, and agrochemicals. Its core product portfolio features Sodium Lauryl Ethyl Sulfate (SLES), Sodium Lauryl Sulfate (SLS), and Cocamidopropyl Betaine (CAPB). With a focus on research and development, the organization provides high-performance ingredients for global fast-moving consumer goods (FMCG) brands. The company operates advanced manufacturing facilities designed to meet international quality standards, ensuring the delivery of surfactants used in shampoos, detergents, and various cleaning agents. Its technical expertise allows for the customization of chemical formulations to meet specific client requirements across domestic and international markets.

Recent filings

Filing Released Lang Actions
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited, clarifying the segment details in the financial results for the quarter and nine months ended December 31, 2025. It references a prior communication about missing segment details in the outcome of a board meeting filing. The letter states the company operates in a single business segment and provides this clarification. The document is short (1289 characters) and serves as a regulatory clarification rather than a full financial report or earnings release. It does not contain financial statements or substantive financial data, nor is it a report itself. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and clarifications that do not fit other categories.
2026-01-31 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of financial results in newspapers. It specifically mentions the 'Extract of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2025' and states that newspaper clippings of these results are enclosed. The document is short (1673 characters) and serves as a notification or announcement of the publication of financial results, not the financial report itself. There is no detailed financial data or analysis within the text, only a statement that the results have been published in newspapers. According to the 'MENU VS MEAL' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-01-21 English
Updates
Interim / Quarterly Report Classification · 92% confidence The document is a formal disclosure under SEBI LODR Regulation 33 and 52 announcing the Board’s approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, including full financial tables and limited review auditor reports. It contains substantive financial data for an interim period, not merely highlights or a link to a report. It thus qualifies as an Interim/Quarterly Report rather than an earnings snapshot or mere announcement. 9M 2025
2026-01-19 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 85% confidence The document is a SEBI LODR Regulation 30 announcement of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, including full financial statements and auditors’ limited review reports. It contains substantive interim period financial data (income statements, notes, review reports), not merely highlights or an attachment notice. This fits the definition of an Interim/Quarterly Report (IR). 9M 2025
2026-01-19 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled to consider and approve the company's un-audited financial results for the quarter and nine months ended December 31, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about Board Meetings. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is essentially an announcement of a forthcoming event related to financial reporting. Given the short length (1522 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2026-01-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.